Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular Resistance.
cardiac output
heart transplantation
non-reversible
pulmonary hypertension
pulmonary vascular resistance
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
02
2022
accepted:
04
04
2022
entrez:
13
5
2022
pubmed:
14
5
2022
medline:
14
5
2022
Statut:
epublish
Résumé
Left ventricular assist devices (LVADs) may reverse elevated pulmonary vascular resistance (PVR) which is associated with worse prognosis in heart failure (HF) patients. We aim to describe the temporal changes in hemodynamic parameters before and after LVAD implantation among patients with or without elevated PVR. HF patients who received continuous-flow LVAD (HeartMate 2&3) at a tertiary medical center and underwent right heart catheterization with PVR reversibility study before and after LVAD surgery. Patients were divided into 3 groups: normal PVR (<4WU); reversible PVR (initial PVR ≥4WU with positive reversibility); and non-reversible (persistent PVR ≥4WU). Overall, 85 LVAD patients with a mean age of 58 years (IQR 49-64), 65 patients (76%) were male; 60 patients had normal PVR, 20 patients with reversible and 5 patients with non-reversible PVR pre-LVAD. All patients with elevated PVR (≥4WU) had higher pulmonary pressures (PP) and increased trans-pulmonary gradient (TPG) compared to patients with normal PVR ( Hemodynamic parameters improved after LVAD implantation, regardless of baseline PVR and reversibility, and enabled heart transplantation in patients who were ineligible due to non-reversible elevated PVR. Our findings suggest that mitigation of elevated non-reversible PVR is related to reduction in PP and increase in CO.
Sections du résumé
Background
UNASSIGNED
Left ventricular assist devices (LVADs) may reverse elevated pulmonary vascular resistance (PVR) which is associated with worse prognosis in heart failure (HF) patients. We aim to describe the temporal changes in hemodynamic parameters before and after LVAD implantation among patients with or without elevated PVR.
Methods
UNASSIGNED
HF patients who received continuous-flow LVAD (HeartMate 2&3) at a tertiary medical center and underwent right heart catheterization with PVR reversibility study before and after LVAD surgery. Patients were divided into 3 groups: normal PVR (<4WU); reversible PVR (initial PVR ≥4WU with positive reversibility); and non-reversible (persistent PVR ≥4WU).
Results
UNASSIGNED
Overall, 85 LVAD patients with a mean age of 58 years (IQR 49-64), 65 patients (76%) were male; 60 patients had normal PVR, 20 patients with reversible and 5 patients with non-reversible PVR pre-LVAD. All patients with elevated PVR (≥4WU) had higher pulmonary pressures (PP) and increased trans-pulmonary gradient (TPG) compared to patients with normal PVR (
Conclusion
UNASSIGNED
Hemodynamic parameters improved after LVAD implantation, regardless of baseline PVR and reversibility, and enabled heart transplantation in patients who were ineligible due to non-reversible elevated PVR. Our findings suggest that mitigation of elevated non-reversible PVR is related to reduction in PP and increase in CO.
Identifiants
pubmed: 35557518
doi: 10.3389/fcvm.2022.875204
pmc: PMC9086513
doi:
Types de publication
Journal Article
Langues
eng
Pagination
875204Informations de copyright
Copyright © 2022 Grupper, Mazin, Faierstein, Kurnick, Maor, Elian, Barbash, Guetta, Regev, Morgan, Segev, Lavee and Fefer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Thorac Cardiovasc Surg. 2007 Mar;133(3):689-95
pubmed: 17320566
J Heart Lung Transplant. 2016 Jan;35(1):1-23
pubmed: 26776864
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D100-8
pubmed: 24355634
J Heart Lung Transplant. 1999 Nov;18(11):1041-53
pubmed: 10598727
J Thorac Cardiovasc Surg. 1997 Oct;114(4):627-34
pubmed: 9338649
J Thorac Cardiovasc Surg. 2010 Oct;140(4):747-9
pubmed: 20850652
Eur J Cardiothorac Surg. 2009 Jun;35(6):1029-34; discussion 1034-5
pubmed: 19211259
J Heart Lung Transplant. 2004 Jun;23(6):716-22
pubmed: 15366432
ESC Heart Fail. 2021 Apr;8(2):908-917
pubmed: 33621427
Eur J Heart Fail. 2003 Oct;5(5):645-53
pubmed: 14607204
Chest. 2020 Jan;157(1):151-161
pubmed: 31446063
Eur J Cardiothorac Surg. 2013 Jun;43(6):1237-42
pubmed: 23345184
Eur J Cardiothorac Surg. 2011 Oct;40(4):971-7
pubmed: 21354812
J Heart Transplant. 1988 Sep-Oct;7(5):331-6
pubmed: 3058901
Am Heart J. 1993 Oct;126(4):896-904
pubmed: 8213447
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
J Card Fail. 2021 May;27(5):552-559
pubmed: 33450411
Eur Heart J. 2016 Mar 21;37(12):942-54
pubmed: 26508169
Turk J Pediatr. 2020;62(3):461-467
pubmed: 32558420
BMJ. 2018 Mar 14;360:j5492
pubmed: 29540357